Medalogix has received a $5 million Series A investment from Connecticut-based Coliseum Capital Management.

Medalogix is a software-as-a-service company that helps providers analyze data to improve patient outcomes.

Currently, Medalogix offers two products called 'Home' and 'Bridge.' Home uses data to help providers reduce readmission rates, and Bridge enables hospital workers to pinpoint patients who are ready to transition to hospice care. The hospice and palliative care industries are growing, said CEO Dan Hogan, who adds that Medalogix can help end-of-life providers make sound choices.

Medalogix has been experiencing rapid growth in both client base and employees, according to the release, and is planning a move into a bigger office space this September.

'This investment is a huge step forward for Medalogix and came at exactly the right time for us to build on the momentum we've had so far in 2014,' Medalogix President and CEO Dan Hogan said in the release. 'We've doubled our staff since December 2013 and have already outgrown one office this year. We've also significantly increased our client count for both our Bridge and Home platforms.'

About Medalogix

Founded in 2012 by former home health agency owner Dan Hogan, Medalogix is the only predictive modeling toolset designed specifically for the post-acute sphere. Medalogix was born from the idea that patients would benefit from a more in-depth analysis of the risks associated with their medications, and that providing this analysis to health care agencies would better equip them to remediate that risk.